Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Monoclonal Protein Response Trajectory and Survival in Newly Diagnosed Multiple Myeloma: A Retrospective Cohort Study

Jayce Bi, BSc, Pascal Lambert, M.Sc., Brett L. Houston, MD, Leonard A. Minuk, MDFRCPC, Vi Dao, MD, Rami Kotb, MD, Donald S. Houston, MD PhD, Ryan Zarychanski, MDMSc,FRCPC, Emily Rimmer, MDFRCPC

Blood (2020) 136 (Supplement 1): 24.

https://doi.org/10.1182/blood-2020-142271

Published: 2020

Journal Articles

Development of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Martha L Louzada, BSc, MD, Alejandro Lazo-Langner, MD, MSC, Vi Dao, MD, Jerry Zhang, MD, Michael J. Kovacs, MD, FRCPC, Marc Carrier, MD, MSc, Marc Rodger, Phil Wells

Blood (2010) 116 (21): 475.

https://doi.org/10.1182/blood.V116.21.475.475

Published: 2010

Journal Articles

Patients with Cancer Who Develop a First Venous Thromboembolic Event After Surgery Are at High Risk of Venous Thromboembolism Recurrence During the Anticoagulation Period

Martha L Louzada, BSc, MD, Alejandro Lazo-Langner, MD, MSC, Marc Carrier, MD, MSc, Vi Dao, MD, Jerry Zhang, MD, Marc A. Rodger, MD, FRCPC, Michael J. Kovacs, MD, FRCPC, Philip Wells, MD, FRCPC, MSc

Blood (2010) 116 (21): 4202.

https://doi.org/10.1182/blood.V116.21.4202.4202

Published: 2010

Journal Articles

Validation of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Martha L Louzada, BSc, MD, Marc Carrier, MD, MSc, Alejandro Lazo-Langner, MD, MSC, Vi Dao, MD, Jerry Zhang, MD, Michael J. Kovacs, MD, FRCPC, Agnes Y. Lee, MD, MSc, Mark N. Levine, MD, MSC, Guy Meyer, MD, Marc Rodger, Philip Wells, MD, FRCPC, MSc

Blood (2010) 116 (21): 4209.

https://doi.org/10.1182/blood.V116.21.4209.4209

Published: 2010

Journal Articles

Oral Warfarin Remains An Effective Treatment Option in the Extended Prophylaxis of VTE for Patients with Cancer: The Effectiveness of the CancerCare Manitoba (CCMB) Anticoagulation Clinic (ACC).

Vi Dao, MD, David Szwajcer, MD, Rick Prayag, PharmD, Don Houston, MD, PhD

Blood (2008) 112 (11): 1283.

https://doi.org/10.1182/blood.V112.11.1283.1283

Published: 2008

Journal Articles

Epidemiology of Adult Acute Lymphoblastic Leukemia in Manitoba, Canada: Does This Approximate Clinical Trial Data?.

Vi Dao, MD, Morel Rubinger, MD, Eric J. Bow, MD, Brent A. Schacter, MD, Tsiporah B. Shore, MD, Donna Woloschuk, Alain Demers, PhD, Xiaoyun Sun, Matthew D. Seftel, MD

Blood (2005) 106 (11): 4554.

https://doi.org/10.1182/blood.V106.11.4554.4554

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Monoclonal Protein Response Trajectory and Survival in Newly Diagnosed Multiple Myeloma: A Retrospective Cohort Study

Development of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Patients with Cancer Who Develop a First Venous Thromboembolic Event After Surgery Are at High Risk of Venous Thromboembolism Recurrence During the Anticoagulation Period

Validation of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Oral Warfarin Remains An Effective Treatment Option in the Extended Prophylaxis of VTE for Patients with Cancer: The Effectiveness of the CancerCare Manitoba (CCMB) Anticoagulation Clinic (ACC).

Epidemiology of Adult Acute Lymphoblastic Leukemia in Manitoba, Canada: Does This Approximate Clinical Trial Data?.

Email alerts

ASH Publications

American Society of Hematology

Update search

Monoclonal Protein Response Trajectory and Survival in Newly Diagnosed Multiple Myeloma: A Retrospective Cohort Study

Development of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Patients with Cancer Who Develop a First Venous Thromboembolic Event After Surgery Are at High Risk of Venous Thromboembolism Recurrence During the Anticoagulation Period

Validation of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Oral Warfarin Remains An Effective Treatment Option in the Extended Prophylaxis of VTE for Patients with Cancer: The Effectiveness of the CancerCare Manitoba (CCMB) Anticoagulation Clinic (ACC).

Epidemiology of Adult Acute Lymphoblastic Leukemia in Manitoba, Canada: Does This Approximate Clinical Trial Data?.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only